$34.75 $0.52 (1.5%)

04:30 PM EDT on 04/24/19

Alkermes, Inc. (NASDAQ:ALKS)

CAPS Rating: 5 out of 5

A biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease.

Current Price $34.75 Mkt Cap $5.3B
Open $34.39 P/E Ratio 0.00
Prev. Close $34.23 Div. (Yield) $0.00 (0.0%)
Daily Range $33.98 - $34.96 Volume 310,018
52-Wk Range $28.22 - $37.63 Avg. Daily Vol. 20

Caps

How do you think NASDAQ:ALKS will perform against the market?

Add Stock to CAPS Watchlist

All Players

329 Outperform
12 Underperform
 

All-Star Players

82 Outperform
2 Underperform
 

Wall Street

10 Outperform
0 Underperform
 

Top NASDAQ:ALKS Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

airenInDebt (65.14)
Submitted August 09, 2018

Several meds currrently in the 3rd stage of the pipeline, two on the market with one being a treatment for opiod addiction makes this a solid investment. A bonus is investing in a company whose products can actually save lives.

PickThatBooger (27.33)
Submitted November 15, 2010

Almost got the top on this one.

NASDAQ:ALKS VS S&P 500 (SPY)

Fools bullish on NASDAQ:ALKS are also bullish on:

Fools bearish on NASDAQ:ALKS are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about ALKS.

Recs

1
Member Avatar airenInDebt (65.14) Submitted: 8/9/2018 4:18:27 PM : Outperform Start Price: $44.59 NASDAQ:ALKS Score: -25.18

Several meds currrently in the 3rd stage of the pipeline, two on the market with one being a treatment for opiod addiction makes this a solid investment. A bonus is investing in a company whose products can actually save lives.

Recs

0
Member Avatar XMFRendezvous (94.36) Submitted: 4/21/2018 1:17:56 AM : Outperform Start Price: $46.31 NASDAQ:ALKS Score: -34.32

Alkermers is primarily involved in producing generic versions or "biosimilars" of already marketed name-brand drugs. The Affordable Care Act encourages the use of generic drugs, which are cheaper. R&D costs are lower, but so are the margins. This is a socially responsible business model, and is the the direction the pharmaceutical industry is headed.

Recs

0
Member Avatar InvestRight (89.91) Submitted: 4/2/2018 4:42:44 PM : Outperform Start Price: $45.02 NASDAQ:ALKS Score: -35.72

Drop is just a better oppurtunity to buy. Management strongly disagrees with the decision and even if they are wrong this biotech is innovating.

Leaderboard

Find the members with the highest scoring picks in ALKS.

Score Leader

Gib323

Gib323 (< 20) Score: +622.96

The Score Leader is the player with the highest score across all their picks in ALKS.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
biofest 72.76 11/10/2009 Outperform 5Y $7.59 +357.84% +167.39% +190.45 1 Comment
lanceur 97.12 11/10/2009 Outperform 5Y $7.62 +356.34% +166.73% +189.61 0 Comment
curlykoa < 20 11/9/2009 Outperform 5Y $7.68 +352.53% +168.12% +184.41 1 Comment
kkotwani 31.83 11/12/2009 11/20/2009 Outperform 5Y $7.93 +338.21% +168.07% +170.14 0 Comment
anticitrademix2 < 20 11/2/2009 Outperform 5Y $8.05 +331.68% +180.69% +150.99 0 Comment
anticitrademix < 20 11/2/2009 Outperform 5Y $8.05 +331.68% +180.69% +150.99 0 Comment
baylesparty1 57.90 11/2/2009 Outperform 5Y $8.05 +331.68% +180.69% +150.99 0 Comment
hankojellyroll < 20 12/14/2009 Outperform 5Y $8.86 +292.21% +161.27% +130.94 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. hayrettin 70.65 12/15/2009 Outperform 5Y $8.85 +292.66% +162.23% +130.43 0 Comment
Dvinity 32.30 11/17/2009 Outperform 5Y $8.88 +291.33% +164.10% +127.23 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
trackmizuho < 20 4/10/2014 Outperform NS $46.22 -24.82% +56.22% -81.04 0 Comment
TrackCitigroup 89.18 1/15/2013 Outperform NS $22.32 +55.69% +99.79% -44.10 0 Comment
TrackZacks < 20 10/1/2012 Outperform 3M $20.64 -2.28% -3.92% +1.65 11/12/2012 @ $20.17 1 Comment
TrackPoisedTo < 20 7/11/2012 Outperform 5Y $17.21 +101.92% +117.70% -15.78 0 Comment
TrackZacks < 20 7/10/2012 Outperform 3M $17.44 +12.39% +9.30% +3.08 9/18/2012 @ $19.60 1 Comment
TrackZacks < 20 12/21/2011 Underperform 3M $17.19 -1.22% +3.12% +4.34 1/5/2012 @ $16.98 1 Comment
TrackZacks < 20 9/13/2011 Outperform 3M $16.08 -4.48% +1.56% -6.04 10/10/2011 @ $15.36 1 Comment
TrackZacks < 20 7/20/2011 Outperform 3M $18.56 -13.79% -4.89% -8.91 8/3/2011 @ $16.00 1 Comment
TrackMKMPartners 90.86 6/21/2011 Outperform NS $17.58 +97.67% +127.70% -30.04 0 Comment
TrackJimCramer 86.01 10/14/2010 Outperform 3W $14.96 +132.29% +148.83% -16.55 0 Comment
TrackUBS 91.30 9/30/2010 Outperform NS $14.75 +135.59% +154.05% -18.45 0 Comment
TrackCarisandCo 85.09 7/14/2010 Outperform NS $12.92 -18.40% +7.73% -26.13 10/20/2010 @ $10.54 0 Comment
TrackJesupLamont 62.03 5/19/2010 Outperform NS $11.41 +204.56% +161.50% +43.06 0 Comment
TrackJefferies 79.13 3/4/2010 Outperform NS $12.07 +187.90% +159.92% +27.98 0 Comment
TrackLeerinkSwan 97.28 11/17/2009 Outperform NS $8.60 +304.07% +163.51% +140.56 0 Comment
TrackLeerinkSwan 97.28 3/3/2009 Outperform NS $9.35 -8.88% +14.26% -23.13 4/7/2009 @ $8.52 0 Comment
TrackZacks < 20 2/9/2009 Underperform 3M $11.50 -22.78% +25.50% +48.28 10/15/2009 @ $8.88 1 Comment
TrackJefferies 79.13 12/19/2008 Outperform NS $10.57 -9.18% +15.07% -24.25 8/27/2009 @ $9.60 0 Comment
TrackRothCapital 74.87 9/17/2008 Outperform NS $12.80 -16.41% -30.10% +13.69 4/3/2009 @ $10.70 0 Comment
trackmerriman 67.45 6/5/2008 Outperform NS $12.50 +4.16% +1.46% +2.70 6/5/2008 @ $13.02 0 Comment
TrackRothCapital 74.87 4/22/2008 Outperform NS $11.31 +31.65% -8.68% +40.34 8/1/2008 @ $14.89 0 Comment
TrackBofASec 91.39 12/18/2007 Outperform NS $14.59 +138.18% +109.93% +28.25 0 Comment
TrackJPMorgan 84.69 11/9/2007 Outperform NS $13.49 -2.82% -18.45% +15.63 4/30/2010 @ $13.11 0 Comment
TrackZacks < 20 5/30/2007 Outperform 3M $16.28 -22.97% -12.53% -10.44 6/18/2008 @ $12.54 1 Comment
TrackFBRCapitalM 85.93 11/3/2006 Outperform NS $14.91 -10.73% -8.72% -2.01 7/10/2008 @ $13.31 0 Comment
TrackJimCramer 86.01 7/31/2006 Underperform 3W $17.16 -12.82% -7.86% +4.97 10/14/2010 @ $14.96 0 Comment
TrackJimCramer 86.01 6/12/2006 Outperform 3W $19.12 -10.25% +3.26% -13.51 7/31/2006 @ $17.16 0 Comment
TrackJimCramer 86.01 4/18/2006 Underperform 3W $21.63 -11.60% -5.42% +6.18 6/12/2006 @ $19.12 0 Comment

Advertisement